Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) EBITDA (2018 - 2025)

Historic EBITDA for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$13.7 million.

  • Health Catalyst's EBITDA fell 2948.9% to -$13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$78.0 million, marking a year-over-year decrease of 756.37%. This contributed to the annual value of -$57.0 million for FY2024, which is 5012.47% up from last year.
  • According to the latest figures from Q3 2025, Health Catalyst's EBITDA is -$13.7 million, which was down 2948.9% from -$33.5 million recorded in Q2 2025.
  • Health Catalyst's EBITDA's 5-year high stood at -$10.6 million during Q3 2024, with a 5-year trough of -$42.8 million in Q4 2021.
  • In the last 5 years, Health Catalyst's EBITDA had a median value of -$29.7 million in 2023 and averaged -$26.4 million.
  • In the last 5 years, Health Catalyst's EBITDA skyrocketed by 5955.5% in 2024 and then tumbled by 16358.7% in 2025.
  • Health Catalyst's EBITDA (Quarter) stood at -$42.8 million in 2021, then grew by 21.56% to -$33.5 million in 2022, then grew by 11.51% to -$29.7 million in 2023, then skyrocketed by 52.16% to -$14.2 million in 2024, then grew by 3.46% to -$13.7 million in 2025.
  • Its last three reported values are -$13.7 million in Q3 2025, -$33.5 million for Q2 2025, and -$16.6 million during Q1 2025.